Basit öğe kaydını göster

dc.contributor.authorErol, Eda
dc.contributor.authorKozacı, Nalan
dc.contributor.authorAvcı, Mustafa
dc.date.accessioned2023-10-02T06:34:06Z
dc.date.available2023-10-02T06:34:06Z
dc.date.issued2022en_US
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85077092964&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=20c4fe371b9b908d4f7e419f791331ff&sot=aff&sdt=cl&cluster=scofreetoread%2c%22all%22%2ct&sl=72&s=AF-ID%28%22Alanya+Alaaddin+Keykubat+University%22+60198720%29+AND+SUBJAREA%28MEDI%29&relpos=56&citeCnt=2&searchTerm=
dc.identifier.urihttps://hdl.handle.net/20.500.12868/2364
dc.description.abstractBackground: Diabetes mellitus is a disease associated with several complications in its acute and chronic stages. Objective: The aim of the study was to determine the treatment-associated changes in optic nerve sheath diameter in patients admitted to the emergency department due to one of the acute hyperglycemic complications of diabetes mellitus. Materials and method: Diabetic patients with serum glucose levels of 250 mg/dL or higher were included in the study. Healthy volunteers were included in the control group. Optic nerve sheath diameter was measured at 0th hour and at the end of the second hour. Blood samples were collected simultaneously with optic nerve sheath diameter measurements. Results: The study included 100 individuals. Group 1 included 50 patients and Group 2 included 50 healthy adults. Optic nerve sheath diameter was 4.5 ± 0.4 mm in Group 1 and 4.4 ± 0.5 mm in Group 2 in 0th hour, and no statistical difference was found between the groups (p = 0.162). In Group 1, optic nerve sheath diameter increased 0.6 ± 0.4 mm after the treatment. Of the patients in Group 1, 22 (44%) patients with diabetic ketoacidosis or hyperosmolar hyperglycemic state were assigned to Group 1A and 28 (56%) patients with isolated hyperglycemia were assigned to Group 1B. There was not a difference between the pre- and post-treatment optic nerve sheath diameter values of the patients in Group 1A and Group 1B. Optic nerve sheath diameter was observed to enlarge after treatment. The difference in optic nerve sheath diameter was 0.6 ± 0.4 mm in Group 1A and 0.5 ± 0.4 mm in Group 1B (p = 0.294). Conclusion: Pre-treatment optic nerve sheath diameter values of the patients who were diagnosed with one of the acute hyperglycemic complications of diabetes mellitus are not different from healthy adults. Furthermore, optic nerve sheath diameter values do not change with the severity of the disease. However, optic nerve sheath diameter values change with treatment. For this reason, optic nerve sheath diameter can be used to following the development of brain edema.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1177/1024907919892161en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBrain edemaen_US
dc.subjectDiabetes mellitusen_US
dc.subjectHyperglycemiaen_US
dc.subjectOcular ultrasounden_US
dc.subjectOptic nerve sheath diameteren_US
dc.titleThe measurement of ultrasonographic optic nerve sheath diameter in patients with hyperglycemiaen_US
dc.typearticleen_US
dc.contributor.departmentALKÜ, Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.identifier.volume29en_US
dc.identifier.issue3en_US
dc.identifier.startpage137en_US
dc.identifier.endpage143en_US
dc.relation.journalHong Kong Journal of Emergency Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster